Insights

Strategic Partnerships Engage in international expansion opportunities via AMI Technologies partnerships to introduce and commercialize fertility products in Israel, amplifying market reach and local adoption.

Clinical Adoption Highlight the first line intrauterine and non surgical birth control capabilities (FemBloc and FemaSeed) to OB/GYN networks and fertility clinics as cost-effective, physician-office solutions that streamline care pathways.

In-office Solutions Promote Femasys' in-office tissue sampling technology as a complementary offering alongside fertility and reproductive health products to drive bundled sales to clinics seeking streamlined workflows.

Market Entry Leverage recent launches and expansions, including FemaSeed Complete at ACOG 2026 and Israeli market entry, to create events and trials that demonstrate real-world adoption and generate early-adopter momentum.

Strategic Financing Leverage the recent $12M senior secured notes financing to support marketing, field trials, and rapid scaling in key markets, positioning Femasys as a growth-focused partner for clinics and health systems.

Similar companies to Femasys Inc.

Femasys Inc. Tech Stack

Femasys Inc. uses 8 technology products and services including Snowplow, Amazon Web Services, WordPress, and more. Explore Femasys Inc.'s tech stack below.

Media & News

Femasys Inc.'s Email Address Formats

Femasys Inc. uses at least 4 email formats:
Femasys Inc. Email FormatsExamplePercentage
FLast@femasys.comJDoe@femasys.com
94%
First.Last@femasys.comJohn.Doe@femasys.com
4%
LFirst@femasys.comDJohn@femasys.com
1%
F.Last@femasys.comJ.Doe@femasys.com
1%

Frequently Asked Questions

What is Femasys Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Femasys Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Femasys Inc.'s stock symbol?

Minus sign iconPlus sign icon
Femasys Inc. is a publicly traded company; the company's stock symbol is FEMY.

What is Femasys Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Femasys Inc.'s official website is femasys.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Femasys Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Femasys Inc.'s annual revenue is estimated to be $1M - $10M.

What is Femasys Inc.'s NAICS code?

Minus sign iconPlus sign icon
Femasys Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Femasys Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Femasys Inc. has approximately 61 employees across 3 continents, including North America, Asia and Europe. Key team members include Vice President Of Finance: G. T., Vice President Of Manufacturing: T. P. and President And Chief Executive Officer: S. L. Explore Femasys Inc.'s employee directory with LeadIQ.

What industry does Femasys Inc. belong to?

Minus sign iconPlus sign icon
Femasys Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Femasys Inc. use?

Minus sign iconPlus sign icon
Femasys Inc.'s tech stack includes Snowplow, Amazon Web Services, WordPress, Module Federation, Barracuda Email Protection, Underscore.js, Microsoft Azure and Astra.

What is Femasys Inc.'s email format?

Minus sign iconPlus sign icon
Femasys Inc.'s email format typically follows the pattern of FLast@femasys.com. Find more Femasys Inc. email formats with LeadIQ.

How much funding has Femasys Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Femasys Inc. has raised $95M in funding. The last funding round occurred on Sep 26, 2025 for $8M.
Femasys Inc. logo

Femasys Inc.

Medical Equipment ManufacturingGeorgia, United States51-200 Employees

Femasys is a biomedical company focused on improving women’s reproductive health through innovative medical solutions. Its lead products include FemBloc, a non-surgical permanent birth control option, and FemaSeed, a directed sperm-delivery treatment for infertility, while FemVue supports fallopian-tube assessment by ultrasound in the United States and the company has developed an in-office tissue-sampling platform.

Headquartered in Suwanee, Georgia, Femasys operates as a mid-sized medical device company serving clinicians and health systems seeking fertility and birth-control options. In 2026, the company announced the commercial launch of FemaSeed Complete at ACOG 2026, signaling an expanded offering within its fertility portfolio.

Section iconCompany Overview

Phone number
Stock Symbol
FEMY
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $95M

    Femasys Inc. has raised a total of $95M of funding over 14 rounds. Their latest funding round was raised on Sep 26, 2025 in the amount of $8M as a Post IPO Equity.

  • $1M - $10M

    Femasys Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.